TriSalus Life Sciences, Inc. — Form D

TriSalus Life Sciences, Inc. of WESTMINSTER, CO, a company, filed a Form D exempt-offering notice with the SEC on 2023-06-22. The offering totals $50.0M, of which $17.9M was reported sold. Industry: Other Health Care.

Offering

Issuer

Officers, directors & promoters (36)

Showing 25 of 36 people.

NameRoleLocation
Manuel H AgueroDirectorGreenwich, CT
CHRISTOPHER C DEWEYDirectorSunrise, FL
Karim KartiDirectorMenlo Park, CA
Martin H RocheDirectorGreenwich, CT
Thierry H ThaureDirectorGreenwich, CT
David L TreadwellDirectorGreenwich, CT
CHRISTOPHER C DEWEYExecutive OfficerSunrise, FL
David J MatlinExecutive OfficerWestminster, CO
Robert H WeissExecutive OfficerGreenwich, CT
Jennifer J StevensExecutive OfficerWestminster, CO
David J MatlinDirectorWestminster, CO
Jodi J DevlinExecutive OfficerWestminster, CO
Arjun F DesaiDirectorWestminster, CO
Sean MurphyDirectorSan Diego, CA
Sean MurphyExecutive OfficerSan Diego, CA
Richard J MarshakExecutive OfficerWestminster, CO
Gary F GordonDirectorWestminster, CO
James YoungExecutive OfficerWestminster, CO
Mary SzelaDirectorWestminster, CO
Mary SzelaExecutive OfficerWestminster, CO
Andrew F von EschenbachDirectorWestminster, CO
Kerry F HicksDirectorWestminster, CO
Brian F CoxExecutive OfficerWestminster, CO
William F ValleDirectorWestminster, CO
Kerry B HicksDirectorWestminster, CO

Other filings by this issuer (2)

FiledFormOfferingSold
2025-05-08D$22.0M$22.0M
2024-12-30D$1000K$1000K

More